TWA
BSTC

TCI Wealth Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

TCI Wealth Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14
Closed – – 1419
2016
Q1 		$0 Buy
+14
New +$514 ﹤0.01% 1443

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCI Wealth Advisors's BSTC Position: Q2 2016 in Review

TCI Wealth Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2016, closing a stake of 14 shares.

TCI Wealth Advisors first reported a position in BSTC in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 90 funds tracked by Wall St. Rank hold BSTC as of Q2 2016.

  • TCI Wealth Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q2 2016 after selling out during the quarter.
  • TCI Wealth Advisors sold 14 BioSpecifics Technologies Corp. shares in Q2 2016.
  • TCI Wealth Advisors first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 1 quarter.
  • TCI Wealth Advisors's BioSpecifics Technologies Corp. position peaked at $0 in Q1 2016.
  • 90 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2016.

Based on TCI Wealth Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.